Marcus Maurer

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria

The <scp>EAACI</scp>/<scp>GA</scp>²<scp>LEN</scp>/<scp>EDF</scp>/<scp>WAO</scp> Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update

The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria

Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria

Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report1

Macrophage inflammatory protein-1

EAACI/GA²LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria

A Comprehensive Guide for the Recognition and Classification of Distinct Stages of Hair Follicle Morphogenesis

Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy

Icatibant, a New Bradykinin-Receptor Antagonist, in Hereditary Angioedema

EAACI/GA²LEN/EDF/WAO guideline: management of urticaria

The international WAO/EAACI guideline for the management of hereditary angioedema—The 2017 revision and update